Agilent Technologies Inc. Reports Strong Financial Performance in 2025
Agilent Technologies Inc. has released its annual report for the fiscal year ending October 31, 2025, showcasing significant financial growth and resilience amid challenging market conditions. The company, a global leader in life sciences, diagnostics, and applied markets, reported a net revenue of $6.948 billion, reflecting a robust 7% increase compared to 2024. This growth has been underpinned by strategic acquisitions, particularly the BIOVECTRA acquisition, which contributed two percentage points to the revenue increase.
1. Overview of Business Segments
Agilent's restructuring in November 2024 resulted in three primary business segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. This strategic move was designed to enhance market focus and optimize customer-centric strategies.
Life Sciences and Diagnostics Markets
This segment led the growth with an impressive 11% increase in revenue, reaching $2.72 billion. The growth was primarily driven by the pharmaceutical market, buoyed by the successful integration of BIOVECTRA. Notably, revenue growth was robust across the Americas, Europe, and Asia Pacific, especially in liquid chromatography and companion diagnostics.
Agilent CrossLab
The Agilent CrossLab segment reported a 6% revenue increase, totaling $2.90 billion. This growth was attributed to strong demand for repair and maintenance services across various end markets, particularly pharmaceuticals and chemicals.
Applied Markets
The Applied Markets segment experienced modest growth of 1%, generating $1.31 billion in revenue. Despite the challenges faced in the academic and government markets, notable gains were made in the food and pharmaceutical sectors.
2. Revenue by Geography
Agilent's revenue growth was well-distributed across geographic regions. The Americas led with $2.80 billion, showing a 9.06% increase from 2024. Europe followed closely with $1.92 billion, marking an 8.64% growth, while the Asia Pacific region contributed $2.21 billion, a 2.4% increase.
3. Key Financial Metrics
Income Statement Highlights
- Net Income: $1.303 billion, slightly up from $1.289 billion in 2024, supported by tax benefits that reduced the overall tax provision.
- Revenue: Increased to $6.948 billion, up from $6.510 billion in 2024.
- Operating Expenses: Totaling $5.46 billion, with costs of revenue at $3.30 billion and operating expenses at $2.16 billion.
| Dec 2024 | Dec 2025 | |
|---|---|---|
Net Income | 1.28B | 1.30B |
Profit | 1.28B | 1.30B |
Net Income Continuing | 1.28B | 1.30B |
Income Tax Expense | 232M | 132M |
Pretax Income | 1.52B | 1.43B |
Non-operating Income | 33M | -44M |
Operating Income | 1.48B | 1.47B |
Revenue | 6.51B | 6.94B |
Costs and Expenses | 5.02B | 5.46B |
Cost of Revenue | 2.97B | 3.30B |
Operating Expenses | 2.04B | 2.16B |
Research & Development | 479M | 455M |
Selling, General & Administrative | 1.56B | 1.70B |
Balance Sheet Overview
As of October 31, 2025, Agilent reported total assets of $12.72 billion, an increase from $11.84 billion in 2024. The company’s equity rose to $6.74 billion, reflecting strong financial health.
| Dec 2024 | Dec 2025 | |
|---|---|---|
Total Assets | 11.84B | 12.72B |
Total Current Assets | 3.95B | 4.59B |
Cash and Equivalents | 1.32B | 1.78B |
Net Inventories | 972M | 1.02B |
Accounts Receivable | 1.32B | 1.48B |
Other Current Assets | 334M | 293M |
Total Non-current Assets | 7.88B | 8.13B |
Intangible Assets | 5.02B | 4.91B |
Long-term Investments | 175M | 133M |
Net PP&E | 1.77B | 2.02B |
Other Non-current Assets | 910M | 1.05B |
Total Liabilities and Equity | 11.84B | 12.72B |
Total Liabilities | 5.94B | 5.98B |
Total Current Liabilities | 1.89B | 2.34B |
Accounts Payable and Accrued Liabilities | 908M | 1.01B |
Current Debt | 45M | 304M |
Current Deferred Revenue | 544M | 624M |
Other Current Liabilities | 398M | 406M |
Total Non-current Liabilities | 4.05B | 3.63B |
Long-term Debt | 3.34B | 3.05B |
Other Non-current Liabilities | 708M | 589M |
Total Equity and Non-controlling Interests | 5.89B | 6.74B |
Total Equity | 5.89B | 6.74B |
Cash Flow Analysis
Agilent's cash flow statement indicated a net change in cash of $459 million, contrasting with a decrease of $261 million in 2024. The company’s strong liquidity position was underscored by cash and cash equivalents of $1.789 billion.
| Dec 2024 | Dec 2025 | |
|---|---|---|
Net Change in Cash | -261M | 459M |
Effect of Exchange Rate Changes | -2M | 9M |
Net Cash from Operating Activities | 1.75B | 1.55B |
Operating Profit | 1.28B | 1.30B |
Adjustment to Operating Profit | 462M | 256M |
Net Cash from Investing Activities | -1.25B | -394M |
Business & Interest in Affiliates | 862M | -4M |
Investments | 18M | -9M |
Productive Assets | 378M | 407M |
Net Cash from Financing Activities | -752M | -715M |
Debt | 637M | -41M |
Dividends | 274M | 282M |
Equity Issuance/Repurchase | -1.07B | -353M |
Other Financing Activities | -42M | -39M |
4. Shareholder Returns and Dividends
Agilent continued to demonstrate its commitment to returning value to shareholders through share repurchase programs and dividends. The company declared cash dividends of $0.992 per share, totaling $282 million for the year, a consistent increase from $274 million in 2024.
5. Challenges and Outlook
Despite the positive financial results, Agilent faced challenges from global tariffs and trade policies that introduced uncertainty in operational results, particularly in the latter half of 2025. The company is proactively addressing these challenges through supply chain optimization and pricing adjustments.
Looking ahead, Agilent remains optimistic about long-term growth opportunities across its segments and continues to invest in innovation and market expansion. The restructuring plan is expected to yield significant cost savings while enhancing customer service capacities.
6. Conclusion
Agilent Technologies, Inc. has demonstrated remarkable resilience and adaptability in its financial performance during 2025. With a clear focus on innovation, strategic acquisitions, and a customer-centric approach, Agilent is well-positioned for continued growth and success in the coming years.
